Annual Accounts Receivable:
$7.77M+$5.33M(+219.15%)Summary
- As of today, NAGE annual accounts receivable is $7.77 million, with the most recent change of +$5.33 million (+219.15%) on December 31, 2024.
- During the last 3 years, NAGE annual accounts receivable has risen by +$4.64 million (+148.50%).
- NAGE annual accounts receivable is now at all-time high.
Performance
NAGE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$8.51M-$1.15M(-11.91%)Summary
- As of today, NAGE quarterly accounts receivable is $8.51 million, with the most recent change of -$1.15 million (-11.91%) on September 30, 2025.
- Over the past year, NAGE quarterly accounts receivable has increased by +$3.41 million (+66.92%).
- NAGE quarterly accounts receivable is now -11.91% below its all-time high of $9.66 million, reached on June 30, 2025.
Performance
NAGE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NAGE Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +219.2% | +66.9% |
| 3Y3 Years | +148.5% | +262.9% |
| 5Y5 Years | +257.1% | +284.2% |
NAGE Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +219.2% | -11.9% | +262.9% |
| 5Y | 5-Year | at high | +257.1% | -11.9% | +284.2% |
| All-Time | All-Time | at high | +2125.2% | -11.9% | +2336.6% |
NAGE Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $8.51M(-11.9%) |
| Jun 2025 | - | $9.66M(+36.9%) |
| Mar 2025 | - | $7.05M(-9.2%) |
| Dec 2024 | $7.77M(+219.1%) | $7.77M(+52.4%) |
| Sep 2024 | - | $5.10M(+18.0%) |
| Jun 2024 | - | $4.32M(+10.6%) |
| Mar 2024 | - | $3.90M(+60.4%) |
| Dec 2023 | $2.43M(-54.8%) | - |
| Dec 2023 | - | $2.43M(-9.9%) |
| Sep 2023 | - | $2.70M(-18.6%) |
| Jun 2023 | - | $3.32M(-42.0%) |
| Mar 2023 | - | $5.72M(+6.3%) |
| Dec 2022 | $5.38M(+72.2%) | $5.38M(+129.6%) |
| Sep 2022 | - | $2.34M(-19.9%) |
| Jun 2022 | - | $2.93M(-27.0%) |
| Mar 2022 | - | $4.01M(+28.3%) |
| Dec 2021 | $3.13M(+16.0%) | $3.13M(+4.4%) |
| Sep 2021 | - | $3.00M(-21.2%) |
| Jun 2021 | - | $3.80M(+13.5%) |
| Mar 2021 | - | $3.35M(+24.2%) |
| Dec 2020 | $2.69M(+23.9%) | $2.69M(+21.7%) |
| Sep 2020 | - | $2.21M(-22.4%) |
| Jun 2020 | - | $2.85M(-6.7%) |
| Mar 2020 | - | $3.06M(+40.6%) |
| Dec 2019 | $2.17M(-50.7%) | $2.17M(-47.5%) |
| Sep 2019 | - | $4.14M(-28.5%) |
| Jun 2019 | - | $5.79M(+7.6%) |
| Mar 2019 | - | $5.38M(+21.9%) |
| Dec 2018 | $4.42M(-17.3%) | $4.42M(-7.5%) |
| Sep 2018 | - | $4.77M(-7.0%) |
| Jun 2018 | - | $5.13M(+7.5%) |
| Mar 2018 | - | $4.77M(-10.6%) |
| Dec 2017 | $5.34M | $5.34M(+8.5%) |
| Sep 2017 | - | $4.92M(+7.4%) |
| Jun 2017 | - | $4.58M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $5.04M(-13.8%) |
| Dec 2016 | $5.85M(+138.8%) | $5.85M(-10.1%) |
| Sep 2016 | - | $6.51M(-4.2%) |
| Jun 2016 | - | $6.79M(+56.9%) |
| Mar 2016 | - | $4.33M(+76.7%) |
| Dec 2015 | $2.45M(+28.5%) | $2.45M(-35.2%) |
| Sep 2015 | - | $3.78M(+22.1%) |
| Jun 2015 | - | $3.10M(+38.7%) |
| Mar 2015 | - | $2.23M(+17.2%) |
| Dec 2014 | $1.91M(+127.3%) | $1.91M(-24.6%) |
| Sep 2014 | - | $2.53M(+19.2%) |
| Jun 2014 | - | $2.12M(+27.2%) |
| Mar 2014 | - | $1.67M(+98.8%) |
| Dec 2013 | $838.80K(-56.8%) | $838.80K(-18.2%) |
| Sep 2013 | - | $1.03M(-13.6%) |
| Jun 2013 | - | $1.19M(-46.0%) |
| Mar 2013 | - | $2.20M(+13.2%) |
| Dec 2012 | $1.94M(+168.1%) | $1.94M(+61.3%) |
| Sep 2012 | - | $1.20M(+21.8%) |
| Jun 2012 | - | $988.20K(-29.4%) |
| Mar 2012 | - | $1.40M(+93.5%) |
| Dec 2011 | $723.70K(-27.7%) | $723.70K(+11.5%) |
| Sep 2011 | - | $648.80K(-22.9%) |
| Jun 2011 | - | $841.90K(-32.0%) |
| Mar 2011 | - | $1.24M(+23.6%) |
| Dec 2010 | $1.00M(+101.2%) | $1.00M(+71.4%) |
| Sep 2010 | - | $584.30K(-30.9%) |
| Jun 2010 | - | $845.60K(+10.0%) |
| Mar 2010 | - | $768.50K(+54.3%) |
| Dec 2009 | $497.90K(+42.6%) | $497.90K(-0.4%) |
| Sep 2009 | - | $499.70K(+19.3%) |
| Jun 2009 | - | $418.70K(-7.9%) |
| Mar 2009 | - | $454.40K(+30.2%) |
| Dec 2008 | $349.10K | $349.10K(-34.4%) |
| Sep 2008 | - | $532.40K(+5.6%) |
| Jun 2008 | - | $504.40K |
FAQ
- What is Niagen Bioscience, Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. annual accounts receivable year-on-year change?
- What is Niagen Bioscience, Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. quarterly accounts receivable year-on-year change?
What is Niagen Bioscience, Inc. annual accounts receivable?
The current annual accounts receivable of NAGE is $7.77M
What is the all-time high annual accounts receivable for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high annual accounts receivable is $7.77M
What is Niagen Bioscience, Inc. annual accounts receivable year-on-year change?
Over the past year, NAGE annual accounts receivable has changed by +$5.33M (+219.15%)
What is Niagen Bioscience, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of NAGE is $8.51M
What is the all-time high quarterly accounts receivable for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high quarterly accounts receivable is $9.66M
What is Niagen Bioscience, Inc. quarterly accounts receivable year-on-year change?
Over the past year, NAGE quarterly accounts receivable has changed by +$3.41M (+66.92%)